A storage bench, which is just as beautiful as it is practical. If you're tired of blankets piling up in bedside chairs — not ...

Creating lasting change often feels daunting, but what if you could transform your life by making small, manageable adjustments? The power of habit stacking lies in its simplicity: by linking new ...

CHICAGO, June 1 (Reuters) - A Gilead Sciences-backed therapy made with a patient's own white blood cells shrank tumors in 62% of patients with recurrent glioblastoma, a rare event for a fatal ...

Perspective from Charu Aggarwal, MD, MPH, FASCO CHICAGO — A 14-gene molecular assay could help predict which patients with early-stage non-small cell lung cancer will benefit from adjuvant ...

"These early, interim results from a promising prospective, randomized study evaluating the role of adjuvant chemotherapy in patients with stage IA-IIA non-small cell lung cancer identified as ...

Among the palette of previously described fluorescent organic molecules, coumarins are ideal candidates for developing cellular and molecular imaging tools due to their high cell permeability and ...

Summit has begun its clinical development of ivonescimab in non-small cell lung cancer (NSCLC), commencing enrollment in 2023 in two multiregional Phase III clinical trials, HARMONi and HARMONi-3 ...

Small inventors already face major challenges competing with large corporations. We can't afford to further stack the deck against them. If policymakers make it more difficult for inventors to secure ...

Regulatory submission is based on positive results from the ongoing Phase I/II SOHO-01 trial in patients with advanced HER2-mutant non-small cell lung cancer (NSCLC). Investigational agent ...

If these lobbyists get their way, small businesses will be the biggest losers. The lobbyists quietly are waging battles in state legislatures and our nation’s capital. Recently, Georgia became ...